Company / strategic investorRegistered location :Allschwil, CH

Idorsia Pharmaceuticals LtdDeclared Swiss shareholdings

Idorsia Pharmaceuticals Ltd: 0 Swiss companies with a declared holding. Latest filing: 10.10.2025.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
—
Swiss companies held
0
Largest position
—
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
10.10.2025
Active since 2018

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 36 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 17

90 days · Downward crossings

0

visible history: 0

First disclosure: 27.11.2018Last disclosure: 10.10.2025

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
17
Rights / derivatives
12

Latest shareholding disclosures

Show 33 older disclosures
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

35.225%Voting rights sold22.10.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

35.225%Voting rights sold16.10.2025
Below thresholdShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

3%Below threshold10.10.2025
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

3.664%Voting rights acquired05.10.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

37.525%Voting rights sold04.10.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

31.283%Voting rights sold29.08.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

61.412%Voting rights sold28.08.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

61.977%Voting rights sold27.05.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

63.032%Voting rights sold19.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

65.297%Voting rights sold18.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

69.324%Voting rights sold12.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

82.198%Voting rights sold04.03.2025
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

8.323%Voting rights acquired08.02.2025
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

52.841%Voting rights sold05.09.2024
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

36.104%Voting rights sold23.03.2024
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

12.99%Voting rights acquired04.03.2023
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

22.13%Voting rights acquired13.01.2023
SaleShareholdings

Idorsia Ltd

Idorsia Pharmaceuticals Ltd · Single shareholder

36.58%Voting rights sold13.01.2023
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

14.73%Voting rights acquired15.03.2022
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

18.45%Voting rights acquired29.09.2021
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

29.82%Voting rights acquired24.09.2021
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

18.41%Voting rights acquired02.09.2021
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

21.29%Voting rights acquired06.08.2021
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

16.81%Voting rights acquired03.06.2021
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

22.94%Voting rights acquired09.02.2021
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

29.24%Voting rights acquired27.10.2020
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

22.34%Voting rights acquired03.10.2020
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

19.59%Voting rights acquired17.09.2020
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

20.33%Voting rights acquired08.09.2020
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

11.97%Voting rights acquired04.09.2020
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

9.39%Voting rights acquired14.08.2020
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

15.32%Voting rights acquired27.11.2018
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Pharmaceuticals Ltd · Single shareholder

13.28%Voting rights acquired27.11.2018

insider24.ch

Follow Idorsia Pharmaceuticals Ltd’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Common questions

Which Swiss companies are in Idorsia Pharmaceuticals Ltd’s disclosed portfolio?

No active holding identified in available disclosures.

What is Idorsia Pharmaceuticals Ltd’s latest disclosure?

The latest available disclosure was published on 19.08.2026 and concerns Idorsia Ltd. Threshold disclosures do not describe every purchase or sale.

Explore further

Recent insider purchases

What are insiders doing at companies disclosed by this shareholder?

All purchases this week

Insider barometer

Compare insider purchases and sales across the Swiss stock exchange over 30 days.

View the Swiss barometer

These signals are not investment advice.